BioNexus Gene Lab Corp. Increase (Decrease) in Other Receivables
BioNexus Gene Lab Corp. (BGLC) reported Increase (Decrease) in Other Receivables of -$150.64 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2024-11-15
- BioNexus Gene Lab Corp. increase (decrease) in other receivables for the quarter ending 2024-09-30 was -$153.28K.
- BioNexus Gene Lab Corp. increase (decrease) in other receivables for the quarter ending 2024-06-30 was -$109.83K.
- BioNexus Gene Lab Corp. increase (decrease) in other receivables for the quarter ending 2024-03-31 was $112.47K.
- BioNexus Gene Lab Corp. increase (decrease) in other receivables for the quarter ending 2023-12-31 was $1.16M.
- BioNexus Gene Lab Corp. increase (decrease) in other receivables for fiscal 2023 was $650.81K, a 20.82% increase from fiscal 2022.
- BioNexus Gene Lab Corp. increase (decrease) in other receivables for fiscal 2022 was $538.65K, a 7.00% decline from fiscal 2021.
- BioNexus Gene Lab Corp. increase (decrease) in other receivables for fiscal 2021 was $579.22K, a 40.91% increase from fiscal 2020.
- BioNexus Gene Lab Corp. increase (decrease) in other receivables for fiscal 2020 was $411.07K, a 4112.64% increase from fiscal 2019.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 3 month as first filed | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 6 month as first filed | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 9 month as first filed | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|---|---|---|
| 2024-09-30 | -$153.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | -$263.11K derived: sum of 2 quarters · filed 2024-11-15 | -$150.64K 10-Q · filed 2024-11-15 | $1.01M derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2024-06-30 | -$109.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $2.64K 10-Q · filed 2024-08-14 | $1.16M derived: sum of 3 quarters · filed 2024-08-14 | $1.01M derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2024-03-31 | $112.47K 10-Q · filed 2024-05-15 | $1.27M derived: sum of 2 quarters · filed 2024-05-15 | $1.12M derived: sum of 3 quarters · filed 2024-11-15 | $1.10M derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2023-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $1.01M derived: sum of 2 quarters · filed 2024-11-15 | $986.32K derived: sum of 3 quarters · filed 2024-11-15 | $650.81K 10-K · filed 2024-04-16 | |||
| 2023-09-30 | -$151.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | -$170.16K derived: sum of 2 quarters · filed 2024-11-15 | -$505.67K 10-Q · filed 2024-11-15 | -$605.42K derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2023-06-30 | -$18.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$354.29K 10-Q · filed 2024-08-14 | -$454.05K derived: sum of 3 quarters · filed 2024-08-14 | -$341.81K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$335.51K 10-Q · filed 2024-05-15 | -$435.27K derived: sum of 2 quarters · filed 2024-05-15 | -$323.03K derived: sum of 3 quarters · filed 2024-05-15 | $533.45K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$99.75K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $12.48K derived: sum of 2 quarters · filed 2024-04-16 | $868.96K derived: sum of 3 quarters · filed 2024-04-16 | $538.65K 10-K · filed 2024-04-16 | |||
| 2022-09-30 | $112.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $968.72K derived: sum of 2 quarters · filed 2022-11-14 | $638.40K 10-Q · filed 2022-11-14 | $1.42M derived: sum of 4 quarters · filed 2023-03-31 | |||
| 2022-06-30 | $856.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $526.16K 10-Q · filed 2022-08-15 | $1.30M derived: sum of 3 quarters · filed 2023-03-31 | $995.94K derived: sum of 4 quarters · filed 2023-03-31 | |||
| 2022-03-31 | -$330.32K 10-Q · filed 2022-05-16 | $447.45K derived: sum of 2 quarters · filed 2023-03-31 | $139.46K derived: sum of 3 quarters · filed 2023-03-31 | $651.75K derived: sum of 4 quarters · filed 2023-03-31 | |||
| 2021-12-31 | $777.77K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $469.78K derived: sum of 2 quarters · filed 2023-03-31 | $982.06K derived: sum of 3 quarters · filed 2023-03-31 | $579.22K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | -$307.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $204.29K derived: sum of 2 quarters · filed 2022-11-14 | -$198.55K 10-Q · filed 2022-11-14 | -$636.02K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $512.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $109.44K 10-Q · filed 2022-08-15 | -$328.03K derived: sum of 3 quarters · filed 2022-08-15 | -$447.56K derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | -$402.85K 10-Q · filed 2022-05-16 | $402.85K 10-Q · filed 2021-05-18 | -$840.31K derived: sum of 2 quarters · filed 2022-05-16 | -$959.85K derived: sum of 3 quarters · filed 2022-05-16 | -$155.57K derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | -$437.46K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | -$557.00K derived: sum of 2 quarters · filed 2022-04-06 | $247.28K derived: sum of 3 quarters · filed 2022-04-06 | $411.07K 10-K · filed 2022-04-06 | |||
| 2020-09-30 | -$119.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $684.74K derived: sum of 2 quarters · filed 2021-11-15 | $848.53K 10-Q · filed 2021-11-15 | -$790.00 10-Q · filed 2020-11-03 | $862.17K derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $804.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $968.07K 10-Q · filed 2021-08-12 | -$110.00 10-Q · filed 2020-08-11 | $981.71K derived: sum of 3 quarters · filed 2021-08-12 | $979.47K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $163.79K 10-Q · filed 2021-05-18 | -$871.00 10-Q · filed 2020-05-08 | $177.43K derived: sum of 2 quarters · filed 2021-05-18 | $175.19K derived: sum of 3 quarters · filed 2021-05-18 | $177.52K derived: sum of 4 quarters · filed 2021-05-18 | ||
| 2019-12-31 | $13.64K derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-03-30 | $11.39K derived: sum of 2 quarters · filed 2021-03-30 | $13.73K derived: sum of 3 quarters · filed 2021-03-30 | $9.76K 10-K · filed 2021-03-30 | |||
| 2019-09-30 | -$2.24K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-09 | $91.00 derived: sum of 2 quarters · filed 2020-11-09 | -$3.88K 10-Q/A · filed 2020-11-09 | ||||
| 2019-06-30 | $2.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$1.64K 10-Q · filed 2020-08-11 | |||||
| 2019-03-31 | -$3.97K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |